Russell Investments Group Ltd. Sells 11,895 Shares of Teladoc Health Inc (NYSE:TDOC)

Russell Investments Group Ltd. lowered its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 17.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 55,824 shares of the health services provider’s stock after selling 11,895 shares during the period. Russell Investments Group Ltd. owned approximately 0.08% of Teladoc Health worth $3,702,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Synovus Financial Corp boosted its holdings in Teladoc Health by 1,277.1% during the second quarter. Synovus Financial Corp now owns 10,714 shares of the health services provider’s stock worth $711,000 after buying an additional 9,936 shares during the last quarter. Tradewinds Capital Management LLC lifted its holdings in shares of Teladoc Health by 186.0% during the 2nd quarter. Tradewinds Capital Management LLC now owns 615 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 400 shares in the last quarter. Cim Investment Mangement Inc. bought a new position in shares of Teladoc Health during the 2nd quarter valued at about $431,000. FineMark National Bank & Trust lifted its holdings in shares of Teladoc Health by 39.1% during the 2nd quarter. FineMark National Bank & Trust now owns 6,675 shares of the health services provider’s stock valued at $443,000 after purchasing an additional 1,875 shares in the last quarter. Finally, Schroder Investment Management Group lifted its holdings in shares of Teladoc Health by 16.4% during the 2nd quarter. Schroder Investment Management Group now owns 245,048 shares of the health services provider’s stock valued at $16,273,000 after purchasing an additional 34,554 shares in the last quarter.

Several equities analysts have recently weighed in on TDOC shares. Svb Leerink reiterated an “outperform” rating on shares of Teladoc Health in a report on Thursday, August 1st. SunTrust Banks lifted their price objective on Teladoc Health to $80.00 and gave the company a “positive” rating in a report on Tuesday, August 6th. Bank of America started coverage on Teladoc Health in a report on Thursday, June 13th. They set a “buy” rating and a $65.00 price objective on the stock. ValuEngine upgraded Teladoc Health from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 27th. Finally, Oppenheimer set a $83.00 price objective on Teladoc Health and gave the company a “buy” rating in a report on Friday, September 6th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $82.58.



In other Teladoc Health news, SVP Andrew Turitz sold 9,158 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $62.27, for a total value of $570,268.66. Following the sale, the senior vice president now owns 6,827 shares in the company, valued at approximately $425,117.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Lewis Levy sold 675 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $60.00, for a total value of $40,500.00. Following the completion of the sale, the insider now owns 4,805 shares in the company, valued at approximately $288,300. The disclosure for this sale can be found here. Insiders sold a total of 114,371 shares of company stock worth $7,763,761 in the last 90 days. Company insiders own 3.14% of the company’s stock.

NYSE TDOC traded down $1.81 during trading on Monday, hitting $68.58. The stock had a trading volume of 8,362 shares, compared to its average volume of 1,154,931. The company has a market capitalization of $4.97 billion, a PE ratio of -47.48 and a beta of 1.35. The company’s 50-day moving average price is $63.05 and its two-hundred day moving average price is $61.32. The company has a debt-to-equity ratio of 0.43, a quick ratio of 7.56 and a current ratio of 7.56. Teladoc Health Inc has a 12 month low of $42.08 and a 12 month high of $89.05.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, July 31st. The health services provider reported ($0.41) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.40) by ($0.01). The firm had revenue of $130.30 million during the quarter, compared to the consensus estimate of $129.54 million. Teladoc Health had a negative net margin of 21.85% and a negative return on equity of 10.64%. The company’s revenue was up 37.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.40) EPS. As a group, equities analysts anticipate that Teladoc Health Inc will post -1.56 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: Most Active Stocks

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.